Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hubbell (HUBB) vs 22nd Century Group Inc (XXII) Price & Performance

22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Hubbell vs 22nd Century Group Inc — how do they compare? Hubbell trades at $473.89 (market cap $25.12B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Hubbell is far larger — about 40407.3× 22nd Century Group Inc's market cap, and Hubbell pays a 1.19% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hubbell for 4 Days and 22nd Century Group Inc for 32 Days on average.

HUBBXXII
Market Cap
$25.12B$621.67K
Volume
784,55745,625
Sector
IndustrialsConsumer Staples
52-Week High
$557.85$483.00
52-Week Low
$407.36$0.80
Typical Hold Time
4 Days32 Days
Enterprise Value
$30.28B-$3.69M
Dividend Yield
1.19%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hubbell

No Aura AI signal available yet.

22nd Century Group Inc

XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.

While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUBB
0% Buy100% Sell
Avg holding period · 4 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

About Hubbell

Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.

Read more on HUBB →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →